,address1,address2,city,state,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,11555 Sorrento Valley Road,Suite 100,San Diego,CA,92121,United States,(858) 224-1000,https://www.organovo.com,Biotechnology,Healthcare,"Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.",23,"{'maxAge': 1, 'name': 'Mr. Keith E. Murphy', 'age': 50, 'title': 'Exec. Chairman', 'yearBorn': 1972, 'fiscalYear': 2023, 'totalPay': 626237, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,1.26,1.24,1.24,1.3799,1.26,1.24,1.24,1.3799,0.0,0.877939,-6.333334,101914,101914,31282,54670,54670,1.25,1.3,800,1300,11595206,1.0,3.4,26.056643,1.479,1.77845,0.0,0.0,USD,2546148,0.0,8620688,8718200,397579,359927,1690761600,1693440000,0.0456,0.00985,0.092209995,13.25,0.0467,1.351,0.984456,1680220800,1711843200,1688083200,-18072000,-2.48,-0.21,1:20,1597795200,5.722,-0.139,NCM,EQUITY,ONVO,ONVO,"Organovo Holdings, Inc.","Organovo Holdings, Inc.",1329229800,America/New_York,EDT,-14400000,1.33,3.0,hold,10754000,1.234,-18377000,1705000,6.16,6.607,445000,14.479,0.051,-0.51562,-0.91666,-8515000,-9263375,-15305000,0.0,0.0,-41.993263,USD,
1,11555 Sorrento Valley Road,Suite 100,San Diego,CA,92121,United States,(858) 224-1000,https://www.organovo.com,Biotechnology,Healthcare,"Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.",23,"{'maxAge': 1, 'name': 'Ms. Vaidehi  Joshi', 'age': 35, 'title': 'Director of Discovery Biology & Director', 'yearBorn': 1987, 'fiscalYear': 2023, 'totalPay': 91403, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,1.26,1.24,1.24,1.3799,1.26,1.24,1.24,1.3799,0.0,0.877939,-6.333334,101914,101914,31282,54670,54670,1.25,1.3,800,1300,11595206,1.0,3.4,26.056643,1.479,1.77845,0.0,0.0,USD,2546148,0.0,8620688,8718200,397579,359927,1690761600,1693440000,0.0456,0.00985,0.092209995,13.25,0.0467,1.351,0.984456,1680220800,1711843200,1688083200,-18072000,-2.48,-0.21,1:20,1597795200,5.722,-0.139,NCM,EQUITY,ONVO,ONVO,"Organovo Holdings, Inc.","Organovo Holdings, Inc.",1329229800,America/New_York,EDT,-14400000,1.33,3.0,hold,10754000,1.234,-18377000,1705000,6.16,6.607,445000,14.479,0.051,-0.51562,-0.91666,-8515000,-9263375,-15305000,0.0,0.0,-41.993263,USD,
2,11555 Sorrento Valley Road,Suite 100,San Diego,CA,92121,United States,(858) 224-1000,https://www.organovo.com,Biotechnology,Healthcare,"Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.",23,"{'maxAge': 1, 'name': 'Mr. Thomas P. Hess CPA, MBA', 'age': 58, 'title': 'Pres & CFO', 'yearBorn': 1964, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,1.26,1.24,1.24,1.3799,1.26,1.24,1.24,1.3799,0.0,0.877939,-6.333334,101914,101914,31282,54670,54670,1.25,1.3,800,1300,11595206,1.0,3.4,26.056643,1.479,1.77845,0.0,0.0,USD,2546148,0.0,8620688,8718200,397579,359927,1690761600,1693440000,0.0456,0.00985,0.092209995,13.25,0.0467,1.351,0.984456,1680220800,1711843200,1688083200,-18072000,-2.48,-0.21,1:20,1597795200,5.722,-0.139,NCM,EQUITY,ONVO,ONVO,"Organovo Holdings, Inc.","Organovo Holdings, Inc.",1329229800,America/New_York,EDT,-14400000,1.33,3.0,hold,10754000,1.234,-18377000,1705000,6.16,6.607,445000,14.479,0.051,-0.51562,-0.91666,-8515000,-9263375,-15305000,0.0,0.0,-41.993263,USD,
3,11555 Sorrento Valley Road,Suite 100,San Diego,CA,92121,United States,(858) 224-1000,https://www.organovo.com,Biotechnology,Healthcare,"Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.",23,"{'maxAge': 1, 'name': 'Dr. Curtis M. Tyree Ph.D.', 'title': 'Sr. VP of Strategy & Bus. Devel.', 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,1.26,1.24,1.24,1.3799,1.26,1.24,1.24,1.3799,0.0,0.877939,-6.333334,101914,101914,31282,54670,54670,1.25,1.3,800,1300,11595206,1.0,3.4,26.056643,1.479,1.77845,0.0,0.0,USD,2546148,0.0,8620688,8718200,397579,359927,1690761600,1693440000,0.0456,0.00985,0.092209995,13.25,0.0467,1.351,0.984456,1680220800,1711843200,1688083200,-18072000,-2.48,-0.21,1:20,1597795200,5.722,-0.139,NCM,EQUITY,ONVO,ONVO,"Organovo Holdings, Inc.","Organovo Holdings, Inc.",1329229800,America/New_York,EDT,-14400000,1.33,3.0,hold,10754000,1.234,-18377000,1705000,6.16,6.607,445000,14.479,0.051,-0.51562,-0.91666,-8515000,-9263375,-15305000,0.0,0.0,-41.993263,USD,
